Bacterial host interactions in cystic fibrosis

Current Opinion in Microbiology

Volumn 15, Issue 1, 2012, Pages 71-77

  Callaghan, Máire ^a   McClean, Siobhán ^a  

^a DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CYTOKINE; IRON; OXYGEN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA DOLOSA; DRUG MEGADOSE; GENE EXPRESSION; GENE MUTATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROSIS; LUNG FUNCTION; MORBIDITY; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; QUORUM SENSING; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

BACTERIAL INFECTIONS; BIOTA; CHRONIC DISEASE; COINFECTION; CYSTIC FIBROSIS; HOST-PATHOGEN INTERACTIONS; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 84856094959     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2011.11.001     Document Type: Review

References (62)

1. Boucher R.C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007, 261:5-16.
2. Lipuma J.J. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010, 23:299-323.
3. Hansen C.R., Pressler T., Nielsen K.G., Jensen P.O., Bjarnsholt T., Hoiby N. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 2010, 9:51-58.
4. Costello A., Herbert G., Fabunmi L., Schaffer K., Kavanagh K.A., Caraher E.M., Callaghan M., McClean S. Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells. J Med Microbiol 2011, 60:289-299.
5. Esther C.R., Esserman D.A., Gilligan P., Kerr A., Noone P.G. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. J Cyst Fibros 2010, 9:117-123.
6. Dalboge C.S., Hansen C.R., Pressler T., Hoiby N., Johansen H.K. Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. J Cyst Fibros 2011, 10:318-325.
7. Tunney M.M., Field T.R., Moriarty T.F., Patrick S., Doering G., Muhlebach M.S., Wolfgang M.C., Boucher R., Gilpin D.F., McDowell A., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 177:995-1001.
8. Tunney M.M., Klem E.R., Fodor A.A., Gilpin D.F., Moriarty T.F., McGrath S.J., Muhlebach M.S., Boucher R.C., Cardwell C., Doering G., et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax 2011, 66:679-684.
9. Schroeder T.H., Lee M.M., Yacono P.W., Cannon C.L., Gerceker A.A., Golan D.E., Pier G.B. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation. Proc Natl Acad Sci USA 2002, 99:6907-6912.
10. Taylor J.B., Hogue L.A., LiPuma J.J., Walter M.J., Brody S.L., Cannon C.L. Entry of Burkholderia organisms into respiratory epithelium: CFTR, microfilament and microtubule dependence. J Cyst Fibros 2010, 9:36-43.
11. Mitchell G., Grondin G., Bilodeau G., Cantin A.M., Malouin F. Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal CFTR function and is influenced by NF-{kappa}B. Infect Immun 2011, 79:3541-3551.
12. McClean S., Callaghan M. Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 2009, 58:1-12.
13. Mullen T., Callaghan M., McClean S. Invasion of Burkholderia cepacia complex isolates into lung epithelial cells involves glycolipid receptors. Microb Pathog 2010, 49:381-387.
14. Chemani C., Imberty A., de Bentzmann S., Pierre M., Wimmerova M., Guery B.P., Faure K. Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 2009, 77:2065-2075.
15. Reeves E.P., Bergin D.A., Murray M.A., McElvaney N.G. The involvement of glycosaminoglycans in airway disease associated with cystic fibrosis. ScientificWorldJournal 2011, 11:959-971.
16. Teichgraber V., Ulrich M., Endlich N., Riethmuller J., Wilker B., De Oliveira-Munding C.C., van Heeckeren A.M., Barr M.L., von Kurthy G., Schmid K.W., et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008, 14:382-391.
17. Becker K.A., Riethmuller J., Luth A., Doring G., Kleuser B., Gulbins E. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis. Am J Respir Cell Mol Biol 2010, 42:716-724.
18. Chun J., Prince A. TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe 2009, 5:47-58.
19. Del Porto P., Cifani N., Guarnieri S., Di Domenico E.G., Mariggio M.A., Spadaro F., Guglietta S., Anile M., Venuta F., Quattrucci S., et al. Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS ONE 2011, 6:e19970.
20. Henke M.O., John G., Rheineck C., Chillappagari S., Naehrlich L., Rubin B.K. Serine proteases degrade airway mucins in cystic fibrosis. Infect Immun 2011, 79:3438-3444.
21. Cosgrove S., Chotirmall S.H., Greene C.M., McElvaney N.G. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J Biol Chem 2011, 286:7692-7704.
22. Kaza S.K., McClean S., Callaghan M. IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol 2010, 301:26-33.
23. Roderfeld M., Rath T., Schulz R., Seeger W., Tschuschner A., Graf J., Roeb E. Serum matrix metalloproteinases in adult CF patients: relation to pulmonary exacerbation. J Cyst Fibros 2009, 8:338-347.
24. Gaggar A., Li Y., Weathington N., Winkler M., Kong M., Jackson P., Blalock J.E., Clancy J.P. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol 2007, 293:L96-L104.
25. Wright C., Pilkington R., Callaghan M., McClean S. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis associated pathogen B. cenocepacia, reduced wound healing in vitro. Am J Physiol 2011, 301:L575-L586.
26. Coakley R.D., Sun H., Clunes L.A., Rasmussen J.E., Stackhouse J.R., Okada S.F., Fricks I., Young S.L., Tarran R. 17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest 2008, 118:4025-4035.
27. Wang Y., Cela E., Gagnon S., Sweezey N.B. Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice. Respir Res 2010, 11:166.
28. Dubin P.J., Kolls J.K. IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice. Am J Physiol Lung Cell Mol Physiol 2007, 292:L519-L528.
29. Hauser A.R., Jain M., Bar-Meir M., McColley S.A. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 2011, 24:29-70.
30. Smith E.E., Buckley D.G., Wu Z., Saenphimmachak C., Hoffman L.R., D'Argenio D.A., Miller S.I., Ramsey B.W., Speert D.P., Moskowitz S.M., et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006, 103:8487-8492.
31. Mena A., Smith E.E., Burns J.L., Speert D.P., Moskowitz S.M., Perez J.L., Oliver A. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 2008, 190:7910-7917.
32. Zlosnik JE, Costa PS, Brant R, Mori PY, Hird TJ, Fraenkel MC, Wilcox PG, Davidson AG, Speert DP: Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. Am J Respir Crit Care Med 2011, 183:67-72.
33. Zlosnik J.E., Speert D.P. The role of mucoidy in virulence of bacteria from the Burkholderia cepacia complex: a systematic proteomic and transcriptomic analysis. J Infect Dis 2010, 202:770-781.
34. Madeira A., Santos P.M., Coutinho C.P., Pinto-de-Oliveira A., Sa-Correia I. Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy. Proteomics 2011, 11:1313-1328.
35. Ulrich M., Bastian M., Cramton S.E., Ziegler K., Pragman A.A., Bragonzi A., Memmi G., Wolz C., Schlievert P.M., Cheung A., et al. The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions. Mol Microbiol 2007, 65:1276-1287.
36. Goerke C., Wolz C. Adaptation of Staphylococcus aureus to the cystic fibrosis lung. Int J Med Microbiol 2010, 300:520-525.
37. Amiel E., Lovewell R.R., O'Toole G.A., Hogan D.A., Berwin B. Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun 2010, 78:2937-2945.
38. Sousa S.A., Ulrich M., Bragonzi A., Burke M., Worlitzsch D., Leitao J.H., Meisner C., Eberl L., Sa-Correia I., Doring G. Virulence of Burkholderia cepacia complex strains in gp91(phox-/-) mice. Cell Microbiol 2007, 9:2817-2825.
39. Sajjan U.S., Yang J.H., Hershenson M.B., LiPuma J.J. Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell Microbiol 2006, 8:1456-1466.
40. Halldorsson S., Gudjonsson T., Gottfredsson M., Singh P.K., Gudmundsson G.H., Baldursson O. Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 2010, 42:62-68.
41. Duff C., Murphy P.G., Callaghan M., McClean S. Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog 2006, 41:183-192.
42. Wilder C.N., Diggle S.P., Schuster M. Cooperation and cheating in Pseudomonas aeruginosa: the roles of the las, rhl and pqs quorum-sensing systems. ISME J 2011, 5:1332-1343.
43. Winstanley C., Fothergill J.L. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections. FEMS Microbiol Lett 2009, 290:1-9.
44. Williams P., Camara M. Quorum sensing and environmental adaptation in Pseudomonas aeruginosa: a tale of regulatory networks and multifunctional signal molecules. Curr Opin Microbiol 2009, 12:182-191.
45. Vikstrom E., Bui L., Konradsson P., Magnusson K.E. Role of calcium signalling and phosphorylations in disruption of the epithelial junctions by Pseudomonas aeruginosa quorum sensing molecule. Eur J Cell Biol 2010, 89:584-597.
46. Wilder C.N., Allada G., Schuster M. Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections. Infect Immun 2009, 77:5631-5639.
47. McKeon S.A., Nguyen D.T., Viteri D.F., Zlosnik J.E., Sokol P.A. Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis. J Infect Dis 2011, 203:383-392.
48. Ryall B., Davies J.C., Wilson R., Shoemark A., Williams H.D. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur Respir J 2008, 32:740-747.
49. Hoboth C., Hoffmann R., Eichner A., Henke C., Schmoldt S., Imhof A., Heesemann J., Hogardt M. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 2009, 200:118-130.
50. Ryall B., Lee X., Zlosnik J.E., Hoshino S., Williams H.D. Bacteria of the Burkholderia cepacia complex are cyanogenic under biofilm and colonial growth conditions. BMC Microbiol 2008, 8:108.
51. Thomas M.S. Iron acquisition mechanisms of the Burkholderia cepacia complex. Biometals 2007, 20:431-452.
52. Visser M.B., Majumdar S., Hani E., Sokol P.A. Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun 2004, 72:2850-2857.
53. Weaver V.B., Kolter R. Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol 2004, 186:2376-2384.
54. Cornelis P., Matthijs S., Van Oeffelen L. Iron uptake regulation in Pseudomonas aeruginosa. Biometals 2009, 22:15-22.
55. Dales L., Ferris W., Vandemheen K., Aaron S.D. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Eur J Clin Microbiol Infect Dis 2009, 28:1275-1279.
56. Caraher E., Reynolds G., Murphy P., McClean S., Callaghan M. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Eur J Clin Microbiol Infect Dis 2007, 26:213-216.
57. Vettoretti L., Plesiat P., Muller C., El Garch F., Phan G., Attree I., Ducruix A., Llanes C. Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 2009, 53:1987-1997.
58. Sass A., Marchbank A., Tullis E., Lipuma J.J., Mahenthiralingam E. Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. BMC Genomics 2011, 12:373.
59. Sun X., Sui H., Fisher J.T., Yan Z., Liu X., Cho H.J., Joo N.S., Zhang Y., Zhou W., Yi Y., et al. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J Clin Invest 2010, 120:3149-3160.
60. Joo N.S., Cho H.J., Khansaheb M., Wine J.J. Hyposecretion of fluid from tracheal submucosal glands of CFTR-deficient pigs. J Clin Invest 2010, 120:3161-3166.
61. Stoltz D.A., Meyerholz D.K., Pezzulo A.A., Ramachandran S., Rogan M.P., Davis G.J., Hanfland R.A., Wohlford-Lenane C., Dohrn C.L., Bartlett J.A., et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010, 2:29ra31.
62. Brodlie M., McKean M.C., Johnson G.E., Perry J.D., Nicholson A., Verdon B., Gray M.A., Dark J.H., Pearson J.P., Fisher A.J., et al. Primary bronchial epithelial cell culture from explanted cystic fibrosis lungs. Exp Lung Res 2010, 36:101-110.